Lung cancer is now the leading cause of cancer death among people living with HIV in the United States.
Read that again.
Not AIDS-defining illnesses. Not opportunistic infections. Lung cancer. A disease with a proven, covered, widely recommended early-detection tool. A disease where screening reduces mortality by approximately 20%. A disease that, if caught early, is survivable.
And yet a new study published in the International Journal of STD & AIDS — covered by The American Journal of Managed Care in October 2026 — found that fewer than 3 in 10 eligible patients living with HIV ever received a low-dose CT scan during a six-year study window.
That is not a guideline failure. The guidelines improved substantially in 2021.
That is not a coverage failure. Low-dose CT screening is covered for qualifying patients.
That is not a contact failure. These patients were already engaged in care, regularly seeing providers for antiretroviral therapy management.
That is an execution failure. And executio…



